Back to User profile » Dr Devalingam Mahalingam
Paper published by Dr Devalingam Mahalingam:
Review
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, Francis Giles
Drug Design, Development and Therapy 2009, 3:89-101
Published Date: 27 March 2009